| Literature DB >> 31139159 |
Xiaoai Zhang1,2, Yanlin Niu1,2, Yuzhu Liu1,2, Zheng Lu1,2, Di Wang1,2, Xia Cui1,2, Qian Chen1,2, Xiaochen Ma1,2.
Abstract
Listeria monocytogenes is an important foodborne pathogen with a significant impact on public health worldwide. A great number of outbreaks caused by L. monocytogenes has been reported, especially in the United States, and European countries. However, listeriosis has not yet been included in notifiable disease in China, and thus information on this infection has been scarce among the Chinese population. In this study, we described a 3-year surveillance of listeriosis in Beijing, China. Fifty-six L. monocytogenes strains isolated from 49 clinical infectious cases (27 pregnancy-associated infections and 22 non-pregnancy-associated infections) were analyzed by serotyping, pulsed field gel electrophoresis (PFGE), multilocus sequence typing (MLST), and antimicrobial susceptibility testing between 2014 and 2016 in Beijing. The predominant serogroups were 1/2a,3a and 1/2b,3b,7 which accounted for 92% of the overall isolates. Four strains were serogroup 4b,4d,4e, isolated from patients with pregnancy-associated infections. Based on PFGE, these isolates were divided into 32 pulsotypes (PTs) and 3 clusters associated with serogroups. Ten PTs were represented by more than one isolate with PT09 containing the most number of isolates. MLST differentiated the isolates into 18 STs, without new ST designated. The three most common STs were ST8 (18.4%), ST5 (16.3%), and ST87 (12.2%), accounting for 46.9% of the isolates. STs prevalent in other parts of the world were also present in China such as ST1, ST2, ST5, ST8, and ST9 which caused maternal fetal infections or outbreaks. However, the STs and serogroup distribution of clinical L. monocytogenes in Beijing, China was different from those in other countries. Strains of ST1 and ST2 were isolated from patients with pregnancy-associated infection, whereas none of ST155 isolates caused pregnancy-associated cases. Surveillance of molecular characterization will provide important information for prevention of listeriosis. This study also enhances our understanding of genetic diversity of clinical L. monocytogenes in China.Entities:
Keywords: China; Listeria monocytogenes; MLST; PFGE; antimicrobial susceptibility; human
Year: 2019 PMID: 31139159 PMCID: PMC6517826 DOI: 10.3389/fmicb.2019.00981
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
The information of patients and isolates analyzed in this study.
| Age | Number of isolates | Gender of patient | Whether or not pregnancy-associated infection# | The outcome of fetus or neonate | |||||
|---|---|---|---|---|---|---|---|---|---|
| Newborns and fetus | 14 | 8 | 3 | 3 | 14 | 0 | 5 | 6 | 3 |
| ≤20 | 7 | 4 | 3 | 0 | 0 | 7 | 0 | 0 | 0 |
| 21∼40 | 24 | 22 | 2 | 0 | 20 | 4 | 13 | 6 | 1 |
| >40 | 11 | 6 | 5 | 0 | 0 | 11 | 0 | 0 | 0 |
| Total | 56 | 40 | 13 | 3 | 34 | 22 | 18 | 12 | 4 |
FIGURE 1Relationships of the isolates based on PFGE. Forty-nine clinical Listeria monocytogenes strains were analyzed by PFGE using AscI and ApaI. The corresponding data, including the name of the strain (Strain ID), the name of the case (Case ID), PFGE types, the type of sample, isolation date, serotype, MLST type (ST), MLST clonal complexes (CC), lineage, and pregnancy-associated were shown alongside the dendrogram to the right.
FIGURE 2The minimum spanning tree of STs of 49 clinical L. monocytogenes strains isolated from Beijing, China. Each circle represents one sequence type. Gray zones surrounding groups of STs represent CC. The size of the circle is proportional to the number of the isolates and the color within the cycles represents the serotypes of the isolates. Links between circles are represented according to the number of allelic mismatches between STs.
FIGURE 3Genetic relationships of the 225 Chinese isolates. A minimum spanning tree was constructed based on STs of 49 isolates from this study and 176 isolates from other studies in China. Each circle represents a sequence type. The size of the circle is proportional to the number of the isolates, and the sources of the isolates were colored as shown in figure. Links between circles are represented according to the number of allelic mismatches between STs.
FIGURE 4Genetic relationships of the 56 clinical isolates in Beijing and 1094 global isolates from L. monocytogenes MLST database. A minimum spanning tree was constructed based on CCs from this study and MLST database. The size of the circle is proportional to the number of the isolates, and the sources of the isolates were colored as shown in figure. The shadow zones in different color represent different clonal complexes.
The resistance rates of 49 L. monocytogenes isolates.
| Antimicrobial | Susceptibility | Resistance | Resistance rate (%) | ||||
|---|---|---|---|---|---|---|---|
| Number of strains | PT | ST | Number of strains | PT | ST | ||
| Cefoxitin (FOX) | 0 | – | – | 49 | 01∼32 | 1, 2, 87, 5, 310, 59, 224, 619, 121, 91, 101, 621, 8, 9, 7, 378, 155, 705 | 100 |
| Daptomycin (DAP) | 3 | 17, 22 | 5, 378 | 46 | 01∼21, 23∼32 | 1, 2, 87, 5, 310, 59, 224, 619, 121, 91, 101, 621, 8, 9, 7, 155, 705 | 93.9 |
| Oxacillin (OXA) | 7 | 06, 07, 08, 09, 13, 22 | 5, 8, 7, 155, 705 | 42 | 01∼05, 10∼12, 14∼21, 23∼32 | 1, 2, 87, 5, 310, 59, 224, 619, 121, 91, 101, 621, 8, 9, 378, 155 | 85.7 |
| Ciprofloxacin (CIP) | 31 | 01∼12, 14∼18, 20, 21, 23∼17, 29∼32 | 1, 2, 87, 5, 59, 224, 619, 121, 101, 621, 8, 9, 378, 155, 705 | 18 | 01∼03, 06, 08, 09, 13, 16, 19, 22, 27, 28, 31 | 1, 5, 310, 619, 121, 91, 8, 7, 155 | 36.7 |
| Tetracycline (TET) | 46 | 01∼06, 09∼32 | 1, 2, 87, 5, 310, 59, 224, 619, 121, 91, 101, 621, 8, 9, 7, 378, 155 | 3 | 07, 08 | 155, 705 | 6.1 |
| Penicillin (PEN) | 47 | 01∼03, 05∼08, 10∼32 | 1, 2, 87, 5, 310, 59, 224, 619, 121, 91, 621, 8, 9, 7, 378, 155, 705 | 2 | 04, 09 | 101, 8 | 4.1 |
| Gentamicin (GEN) | 48 | 01∼32 | 1, 2, 87, 5, 310, 59, 224, 619, 121, 91, 101, 621, 8, 9, 7, 378, 155, 705 | 1 | 09 | 8 | 2.0 |
| Ampicillin (AMP) | 49 | 01∼32 | 1, 2, 87, 5, 310, 59, 224, 619, 121, 91, 101, 621, 8, 9, 7, 378, 155, 705 | 0 | – | – | 0 |
| Vancomycin (VAN) | 49 | 01∼32 | 1, 2, 87, 5, 310, 59, 224, 619, 121, 91, 101, 621, 8, 9, 7, 378, 155, 705 | 0 | – | – | 0 |
| Clindamycin (CLI) | 49 | 01∼32 | 1, 2, 87, 5, 310, 59, 224, 619, 121, 91, 101, 621, 8, 9, 7, 378, 155, 705 | 0 | – | – | 0 |
| Erythromycin (ERY) | 49 | 01∼32 | 1, 2, 87, 5, 310, 59, 224, 619, 121, 91, 101, 621, 8, 9, 7, 378, 155, 705 | 0 | – | – | 0 |
| Chloramphenicol (CHL) | 49 | 01∼32 | 1, 2, 87, 5, 310, 59, 224, 619, 121, 91, 101, 621, 8, 9, 7, 378, 155, 705 | 0 | – | – | 0 |
| Trimethoprim-sulfamethoxazole (SXT) | 49 | 01∼32 | 1, 2, 87, 5, 310, 59, 224, 619, 121, 91, 101, 621, 8, 9, 7, 378, 155, 705 | 0 | – | – | 0 |